The Scripps Research Molecular Screening Center,
Department of Molecular Medicine,
The Scripps Research Molecular Screening Center, Department of Molecular Medicine
Dr. Louis Scampavia is a faculty member at Scripps Research within the Department of Molecular Medicine; leveraging nearly four decades of research experience. Having been at the Scripps Florida at its very inception, he currently serves as the Senior Scientific Director of HTS Chemistry and Technologies. The Scripps Molecular Screening High Throughput Screening Center is focused on drug discovery to support academic investigators and industrial partners. Duties include establishing collaborations with other biomedical researchers to facilitate the development of screening assays for HTS compatibility; having the ultimate goal of discovering novel therapeutics or re-purposing current ones. Dr. Scampavia currently serves as an investigator on a number of NIH grants and has also often served as a NIH/NCI peer grant reviewer.
Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
Journal of biomolecular screening Jan, 2008 | Pubmed ID: 18227223
A time-resolved fluorescence-resonance energy transfer assay for identifying inhibitors of hepatitis C virus core dimerization.
Assay and drug development technologies Feb, 2010 | Pubmed ID: 20035614
Monitoring of HTS compound library quality via a high-resolution image acquisition and processing instrument.
Journal of laboratory automation Jun, 2011 | Pubmed ID: 21609702
Identification of Potent and Selective Inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PfM18AAP) of Human Malaria via High-Throughput Screening.
Journal of biomolecular screening Aug, 2014 | Pubmed ID: 24619116
Development of high throughput screening assays and pilot screen for inhibitors of metalloproteases meprin α and β.
Biopolymers Sep, 2014 | Pubmed ID: 25048711
Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening.
Journal of biomolecular screening Jan, 2015 | Pubmed ID: 25163684
Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4).
Journal of biomolecular screening Aug, 2015 | Pubmed ID: 25877150
An Automated Miniaturized Method to Perform and Analyze Antimicrobial Drug Synergy Assays.
Assay and drug development technologies Jan-Feb, 2016 | Pubmed ID: 26669516
Fluorometric High-Throughput Screening Assay for Secreted Phospholipases A2 Using Phospholipid Vesicles.
Journal of biomolecular screening Aug, 2016 | Pubmed ID: 27146384
Identification of Potential Pharmacoperones Capable of Rescuing the Functionality of Misfolded Vasopressin 2 Receptor Involved in Nephrogenic Diabetes Insipidus.
Journal of biomolecular screening Sep, 2016 | Pubmed ID: 27280550
Development of an HTS-Compatible Assay for Discovery of Melanoma-Related Microphthalmia Transcription Factor Disruptors Using AlphaScreen Technology.
SLAS discovery : advancing life sciences R & D 01, 2017 | Pubmed ID: 27827304
A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids.
SLAS discovery : advancing life sciences R & D 06, 2017 | Pubmed ID: 28346088
A Rapid Phenotypic Whole-Cell Screening Approach for the Identification of Small-Molecule Inhibitors That Counter β-Lactamase Resistance in Pseudomonas aeruginosa.
SLAS discovery : advancing life sciences R & D 01, 2018 | Pubmed ID: 28850797
High-Throughput Screening for Protein Synthesis Inhibitors Targeting Aminoacyl-tRNA Synthetases.
SLAS discovery : advancing life sciences R & D 02, 2018 | Pubmed ID: 29020503
Using bead injection to model dispensing of 3-D multicellular spheroids into microtiter plates.
Talanta Jan, 2018 | Pubmed ID: 29108585
A Homogeneous Cell-Based Halide-Sensitive Yellow Fluorescence Protein Assay to Identify Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Ion Channel.
Assay and drug development technologies Dec, 2017 | Pubmed ID: 29172645
IoT for Real-Time Measurement of High-Throughput Liquid Dispensing in Laboratory Environments.
SLAS technology 10, 2018 | Pubmed ID: 29649373
Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening.
SLAS discovery : advancing life sciences R & D 07, 2018 | Pubmed ID: 29673279
A novel three-dimensional high-throughput screening approach identifies inducers of a mutant KRAS selective lethal phenotype.
Oncogene 08, 2018 | Pubmed ID: 29743592
A Cytotoxic Three-Dimensional-Spheroid, High-Throughput Assay Using Patient-Derived Glioma Stem Cells.
SLAS discovery : advancing life sciences R & D 09, 2018 | Pubmed ID: 29750582
Identification of Antimalarial Inhibitors Using Late-Stage Gametocytes in a Phenotypic Live/Dead Assay.
SLAS discovery : advancing life sciences R & D Jan, 2019 | Pubmed ID: 30142014
Design of Microplate-Compatible Illumination Panels for a Semiautomated Benchtop Pipetting System.
SLAS technology Aug, 2019 | Pubmed ID: 30698997
Automating a Magnetic 3D Spheroid Model Technology for High-Throughput Screening.
SLAS technology Aug, 2019 | Pubmed ID: 31225974
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved